Population Health & ICB Programmes
Population Medicines Optimisation Programme
System-wide medicines optimisation for ICBs.
What medicines optimisation support does BCS offer ICBs?
BCS runs system-wide medicines optimisation programmes for ICBs: population searches, targeted reviews, practice support and system-level reporting.
Reviewed October 2026 by the BCS clinical services team.
What is this service?
Population Medicines Optimisation Programme from Bespoke Clinical Services: system-wide medicines optimisation for ICBs. Every arrangement is built around your organisation — truly bespoke, never off-the-shelf.
What can BCS support?
- Population searches
- Targeted reviews
- Practice support
- System reporting
How can it be delivered?
- Commissioned programmes
- Neighbourhood teams
- Outcomes reporting
- As a defined project — no permanent contract needed
Who makes clinical decisions?
Pharmacists and technicians complete tasks within their competence and agreed scope. Medical decisions, complex cases and prescription authorisation sit with the GP. All clinicians follow your organisation's clinical governance and procedures.
How clinical governance works →How does delivery start?
We agree the workload, scope, system access, escalation routes and reporting with you, complete clinician checks and induction, then start delivery. Progress is reviewed with you regularly.
Ways to commission →Why choose BCS?
BCS is a truly bespoke clinical services partner. We support 50+ PCNs and 300+ GP practices with 150+ clinical pharmacists, delivered from two hubs in Halifax and London. Every clinician is backed by our management layer, structured training, clinical supervision and quality assurance, and activity is reported clearly through the BCS Impact Dashboard.
How is it funded?
Typically commissioned by an ICB, federation or provider collaborative as a defined programme or service contract.
Read our funding and ARRS guide →Common questions
What medicines optimisation support does BCS offer ICBs?
BCS runs system-wide medicines optimisation programmes for ICBs: population searches, targeted reviews, practice support and system-level reporting.
Who is Population Medicines Optimisation Programme for?
It's designed for icbs, gp federations, primary care networks. Every arrangement is tailored to your organisation.
Can population medicines optimisation programme be delivered remotely?
Yes. It can be delivered remotely, on-site, or a mix of both, from our hubs in Halifax and London.
Is population medicines optimisation programme ARRS funded?
Typically commissioned by an ICB, federation or provider collaborative as a defined programme or service contract.
Who makes clinical decisions in population medicines optimisation programme?
Pharmacists and technicians complete tasks within their competence and agreed scope. Medical decisions, complex cases and prescription authorisation sit with the GP. All clinicians follow your organisation's clinical governance and procedures.
How does population medicines optimisation programme start?
We agree the workload, scope, system access, escalation routes and reporting with you, complete clinician checks and induction, then start delivery. Progress is reviewed with you regularly.
Do I need a full-time contract?
No. You can commission a defined project with an agreed scope and timeline, without a permanent staffing agreement.
Request Population Medicines Optimisation Programme
Tell us a little about your organisation and we'll come back within one working day with a bespoke proposal.
